Thus, the present study is vital to analyze and provide new insights into the molecular and therapeutic aspects of IL-6 mediated JAK2/STAT3 signaling, to affirm the role of the newly synthesized IFBOs in NDEA induced experimental HCC in rats. The gene discussed is IL6; the disease is hepatocellular carcinoma.